Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuPreviq: Personalized Prophylaxis with Nuwiq in Severe Hemophilia A
NCT01863758Phase 3Completed
- Sponsor
- Octapharma
- Start
- Aug 2013
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started Aug 2013; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01863758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863758.